<- Go Home

Getinge AB (publ)

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company offers surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it provides pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Market Cap

SEK 56.1B

Volume

937.8K

Cash and Equivalents

SEK 1.9B

EBITDA

SEK 5.0B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

SEK 16.6B

Profit Margin

46.89%

52 Week High

SEK 226.30

52 Week Low

SEK 164.35

Dividend

2.23%

Price / Book Value

1.95

Price / Earnings

37.66

Price / Tangible Book Value

-9.57

Enterprise Value

SEK 65.5B

Enterprise Value / EBITDA

11.78

Operating Income

SEK 3.8B

Return on Equity

4.97%

Return on Assets

4.24

Cash and Short Term Investments

SEK 1.9B

Debt

SEK 11.2B

Equity

SEK 29.0B

Revenue

SEK 35.5B

Unlevered FCF

SEK 4.4B

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches